CareLit Fachartikel
Serum CCL18 Levels Predict Survival and Disease Progression in IPF Patients Treated with Antifibrotic Drugs
Canay Caliskan, Benedikt Jäger, Oliver Terwolbeck, Rosa Apel, Antje Prasse · Pneumologie · 2019 · Heft 02
Dokument
1195055
CareLit-ID
Jahr
2019
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig
Bibliografische Angaben
Zusammenfassung
Serum CCL18 Levels Predict Survival and Disease Progression in IPF Patients Treated with Antifibrotic Drugs
Schlagworte
Serum
Ccl18
Levels
Predict
Survival
Disease
Progression
Patients
Treated
Antifibrotic
Drugs
Pneumologie